£185.00
Discusses new treatment strategies for malignant mesothelioma, pulmonary edema, fibrosis, asthma, emphysema, and bronchiectasis.
Proteoglycans in Lung Disease considers
• glycosaminoglycans as novel therapeutic agents or targets in lung disease
• the role of proteoglycans in determining mechanical behavior of lung tissue
Natural Polymeric Materials based Drug Delivery Systems in Lung Diseases
Lung Inflammation in Health and Disease, Volume II
Clinical Research Involving Pulmonary Disorders
Membranes in Pulmonary Vascular Disease
Pulmonary Disorders and Therapy
Aging Lungs, The: Mechanisms And Clinical Sequelae
Lung Inflammation in Health and Disease, Volume I
Treatment of Cystic Fibrosis and Other Rare Lung Diseases
Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems
Stem Cell-Based Therapy for Lung Disease
Asbestos and Mesothelioma
Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases